Research Article
Clinical Characteristics of Pregnancy-Associated Central Serous Chorioretinopathy in the Chinese Population
Table 1
Demographic characteristics and clinical data of Chinese patients with pregnancy-associated central serous chorioretinopathy.
| Case | Age (years) | BP at initial visit (mmHg) | Number of the current pregnancy | History of CSC in the first pregnancy | Eye | Gestational week at onset of current CSC (weeks) | Duration of symptoms of CSC at initial visit (days) | BCVA at initial visit (Snellen) | Number of RPE abnormal sites on OCT | Treatment | Follow-up duration | BCVA at final visit (Snellen) | Subretinal fluid at final visit | EZ status at fovea at final visit |
| 1 | 34 | 120/79 | 1 | | OD | 31 + 2 | 5 | 20/100 | 1 | N/A | N/A | N/A | N/A | N/A | 2 | 33 | 116/73 | 1 | | OS | 26 | 14 | 20/25 | 1 | No | PPD 70 days | 20/20 | None | Intact | 3 | 42 | 105/70 | 1 | | OD | 27 | 28 | 20/50 | mf | No | PPD 144 days | 20/20 | None | Intact | | | | | | OS | 27 + 2 | 26 | 20/50 | mf | Half-dose PDT | PPD 56 months (after half-dose PDT 30 months) | 20/50 | None | Discontinuous | 4 | 35 | 110/70 | 1 | | OD | 29 | 30 | 20/60 | mf | No | PPD 35 days | 20/25 | None | Intact | | | | | | OS | 29 | 30 | 20/60 | mf | No | PPD 35 days | 20/30 | None | Intact | 5 | 36 | 100/80 | 2 | Yes | OD | 27 + 5 | 2 | 20/30 | mf | No | GW 35 | 20/20 | None | Intact | 6 | 34 | 110/70 | 2 | No | OS | 28 | 3 | 20/40 | 1 | N/A | N/A | N/A | N/A | N/A | 7 | 29 | 121/71 | 2 | Yes | OD | 25 + 4 | 38 | 20/25 | 1 | No | PPD 6 weeks | 20/20 | None | Intact | 8 | 40 | 116/66 | 1 | | OD | 24 + 2 | 7 | 20/50 | mf | N/A | N/A | N/A | N/A | N/A | 9 | 32 | 120/80 | 2 | No | OD | 27 + 4 | 34 | 20/50 | 1 | N/A | N/A | N/A | N/A | N/A |
|
|
BCVA, best-corrected visual acuity; BP, blood pressure; CSC, central serous chorioretinopathy; EZ, ellipsoid zone; GW, gestational week; mf, multifocal; N/A, not applicable; OCT, optical coherence tomography; PDT, photodynamic therapy; PPD, postpartum day; Y, yes.
|